Enhabit, Inc.

EHAB

Enhabit, Inc.

EHAB/Services-Home Health Care Services/DE

We are a leading provider of home health and hospice services in the United States. We strive to provide our patients with superior clinical care, where our patients prefer it: in their homes.

⊜ Compare

ProfitabilityN/A GrowthModerating Cash FlowHealthy conversion ValuationN/A

What's changing

Revenue growth slowed to 2.4%, essentially flat. This is a business that needs a catalyst.

What deserves caution

Net debt of $461M represents 7.0x FCF, leverage limits flexibility.

Profitability & Returns

TTM as of 2026-03 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue (TTM)

$1.06B

▲ +2.4% YoY

Net Income (TTM)

-$3M

▲ +97.1% YoY

Op. Margin

—

ROIC

—

Cash Flow & Balance Sheet

FCF = operating cash flow + capex · Net debt = total debt − cash · Balance sheet from latest filing

FCF (TTM)

$81M

▲ +38.8% YoY

Op. Cash Flow (TTM)

$88M

▲ +38.1% YoY

Net Debt

$434M

Cash & Equiv.

$50M

5Y CAGR: -0.3%

5Y CAGR: +24.8%

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

DCF Valuation

What is it worth?

Financials

Full income, cash flow, balance sheet

SourceComputed from the 10-Q filed 4 May 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 5 Sept 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.

Related stocks: Services-Home Health Care Services

ADUSAddus HomeCare Corporation

CHEChemed Corporation

AVAHAveanna Healthcare Holdings Inc.

AHCOAdaptHealth Corp.

OPCHOption Care Health Inc.

PNTGThe Pennant Group, Inc.

CAICaris Life Sciences, Inc.

INNVInnovAge Holding Corp.

Spot a number that looks wrong? Check it in EHAB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EHAB

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.